Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.
UCSF Comprehensive Cancer Center.
Margaret
M
Tempero
J Pablo
JP
Arnoletti
Edgar
E
Ben-Josef
Pankaj
P
Bhargava
Ephraim S
ES
Casper
Paula
P
Kim
Mokenge P
MP
Malafa
Eric K
EK
Nakakura
Stephen
S
Shibata
Mark
M
Talamonti
Hanlin
H
Wang
Christopher
C
Willett
D000230:Adenocarcinoma / Q000175:diagnosis / Q000601:surgery; D000465:Algorithms; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002779:Cholestasis / Q000209:etiology; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019468:Disease Management; D004322:Drainage; D017219:Gastric Outlet Obstruction / Q000209:etiology; D006801:Humans; D008197:Lymph Node Excision; D009367:Neoplasm Staging / Q000145:classification; D010166:Palliative Care; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000601:surgery; D011169:Portal Vein / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome; D000093542:Gemcitabine
D015295:Antigens, Tumor-Associated, Carbohydrate; D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine